HIGHLIGHTS
- who: Jeongrae Kim and collaborators from the Graduate School of Converging Science and Technology, Korea University, Anam-ro have published the Article: Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses, in the Journal: Pharmaceutics 2022, 14, 474. of 28/01/2022
- what: The primary reason of this reduced cytotoxicity of DOX from DP-NPs was its sustained-release property.
- how: These results were analyzed using FlowJoTM software (BD Biosciences NJ USA).
SUMMARY
All these features and behaviors of DP-NPs were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.